期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

2型糖尿病患者糖尿病肾病危险因素分析 被引量：2

Analysis of Risk Factors of Diabetic Nephropathy in Type 2 Diabetic Patients
下载PDF
导出
摘要 目的 :分析糖尿病肾病 (DN)相关危险因素。方法 :随机抽取糖尿病 (DM )患者1211例 ,根据24h尿白蛋白排泄率 (UAER)将其分3组。结果 :(1)相关分析示UAER与年龄、病程、餐后血糖 (PBG)、收缩压 (SBP)、舒张压 (DBP) ,血清尿酸 (SUA)、甘油三酯 (TG)、纤维蛋白原 (FIB) ,餐后胰岛素 (PINS)、胰岛素抵抗指数 (IR)和24h尿尿酸 (UUA)等多变量呈正相关。(2)回归分析示病程、24hUUA、TC、FIB、IR为DN的独立危险因素。结论 :DN的危险因素有多种 ,主要与胰岛素抵抗 ,血胆固醇 (TC)。 Objective:To evaluate the risk factors of diabetic nephropathy in type 2 diabetic patients.Methods: 1 211 type 2 diabetes mellitus patients were divided into three groups according to urine albumin excretion rate(UAER).Results:(1)There were positive correlations between UAER and age,illness duration,PBG,SBP,DBP,SUA,TG,FIB,PINS,IR, 24 h uric acid of urine(UUA).(2)Illness duration,24 h UUA,TC,FIB,IR were independent risk factors of diabetic nephropathy.Conclusion:There are many risk factors in diabetic nephropathy.It is possibly associated with IR,high TC,high FIB,and increased 24 h UUA.
作者 孙丽荣 赵伟 于德民 刘倩 管乐 王世颖 王家驰
机构地区 天津医科大学代谢病医院
出处 《天津医药》 CAS 北大核心 2004年第4期214-216,共3页 Tianjin Medical Journal
关键词 2型糖尿病 糖尿病肾病 危险因素 血清尿酸 甘油三酯 纤维蛋白原 diabetes mellitus,non-insulin-dependent diabetic nephropathies albuminuria risk factors
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献9

二级参考文献18

  • 1陈清棠 主编.临床神经病学[M].北京:北京科学技术出版社,2002.178.
  • 2[1]McCormack LJ, Nagi DK, Grant PJ, et al. Plasminogen activator inhibitor-1 genotype (4G/5G) in Pima Indians:relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome. Diabetologia,1996.1512-1518.
  • 3[2]Mojca S, Pavel U, Bernd RB, et al. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 gene:relationship to plasma PAI-1 level in venous thromboembolism. Thromb Haemost,1998,79:975-979.
  • 4[3]Yumiko M, Mitsuru M, Yasuo I, et al.Genotype frequency of plasminogen activator inhibitor-1(PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.International J Hematol,1999,69:43-47.
  • 5[4]Andreas G, Jana L, Werner H, et al.The 4G/5G genotype of the plasminogen activator inhibitor-1 gene polymorphism is associated with coronary atherosclerosis in patients at high risk for this disease. Thromb Haemost,1999,82:1121-1126.
  • 6[5]Grancha S, Esrelles A, Aznar J, et al. Plasminogen activator inhibitor-1(PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.Thromb Haemost,1999, 81:516-21.
  • 7[6]Maria TS, Antonio G, Gilvaurizio P, et al. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Thromb Haemost,1998,80:956-60.
  • 8[7]Michael W, Mansfield J. Environmental and genetic factors in relation to elevated circulating levels of PAI-1 in caucasian patients with type two diabetes.Thromb Haemost,1997,79:842-847
  • 9[8]Potter BJ, Kluft C, Radder JK, et al.The cardiovascular risk factor PAI-1 is related to insulin resistance. Metabolism,1993,43:945-949.
  • 10[9]Haffner SM, DAgostino R Jr, Tracy R, et al.Sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care, 1999, 22:4,562-568.

共引文献877

同被引文献18

  • 1赵昉.2型糖尿病合并早期糖尿病肾病的相关危险因素分析[J].长治医学院学报,2007,21(4):259-261. 被引量：3
  • 2Babu N ,Singh M. N.babu ,M.SinghAnalysis of aggregation parameters of ethroytes in diabetes mellitus[J]. Clin.HemorheokMicrocirc,2005,52 (4) : 269-277.
  • 3Riquelme B, Foresto P, D'Arrigo M, et al. A dynamic and stationary rher- logical study of erythrocytes incubated in a glucose medium[J]. J Biochem. Biophys, Methods, 2005,62 (2) : 131-1 4 1.
  • 4Khan MA, Collins A J, Keane WF. KHAN MA, COLLINS AJ KEANE WF. Diabetes in the elderly population[J]. Adv Ren Replace Ther, 2000,7 ( 1 ) : 32-51.
  • 5Marchesi VT, Furthmayr H,Tomita M. The red cell membrane[J]. Annu Rev Biochem. 1976.45 : 667-698.
  • 6Haskins K ,Bradley B ,Powers K,et al. Oxidative stress in type 1 diabetes[J]. Ann N Y Acad Sci ,2003,1005:43-54.
  • 7Stentz FB, Umpierrez GE, Cuervo R, et al. Proinnammatory Proinflamma- tory cytokines, markers of cardiovascular risks, oxidatiwe oxidative stress, and lipid peroxidation in patients with hyperglycemic crises[J]. Diabetes, 2004,53 ( 8 ) : 2079-2086.
  • 8Babu N ,Singh M. N.babu ,M.Singh.Influence of hyperglycemia on aggre- gation,deformability and shape parameters of erythrocytes[J]. Clin Hemor- heol Microcirc .2004,31 (4) :273-280.
  • 9Btiytlkkoak S,Ozttlrk HS,Tamer MN,et al. Erythrocyte oxidant/antioxi- dant status of diatebtic diabetic pantientspatients[J]. J Endocrinol Invest, 2000,23 (4) : 228-230.
  • 10Le D6v6hat C ,Vimeux M ,Khodabandehlou T. C. ,et al. Blood rheology in patients with diatetes diabetes Mellitus mellitus [J]. Clin Hemol Microcir, 2004,30 (3/4) : 297-300.

引证文献2

二级引证文献10

天津医药
2004年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部